COLLEEN SAWYER
CHARLOTTESVILLE, VA
Browse related groups: VA Genentech, Inc. All categories
This page merges CMS profile IDs: 11389399, 11586580 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$439.93
- Category: General Payments
- Program years: PY2021–2024
- Record count: 10
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $226.99 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $226.99 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Genentech, Inc. | $133.54 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.74 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $24.97 | 1 |
| Janssen Biotech, Inc. | $17.87 | 1 |
| Phathom Pharmaceuticals, Inc. | $15.87 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078794163 | Janssen Biotech, Inc. | $17.87 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133151894 | Genentech, Inc. | $100.21 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133151898 | Genentech, Inc. | $33.33 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137819940 | Takeda Pharmaceuticals U.S.A., Inc. | $16.22 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137819942 | Takeda Pharmaceuticals U.S.A., Inc. | $18.52 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151203257 | Phathom Pharmaceuticals, Inc. | $15.87 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153546549 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $24.97 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 11389399, 11586580
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.